Predict your next investment

Investment Bank
cowen.com

See what CB Insights has to offer

Investments

183

Portfolio Exits

79

Funds

4

Partners & Customers

10

About Cowen

Cowen is a financial services firm providing alternative investment management, investment banking, research, and sales and trading services through its business units, Ramius and Cowen and Company. Its alternative investment management products include hedge funds, fund of funds, real estate, healthcare royalty funds and cash management, offered primarily under the Ramius name. Cowen offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors.

Cowen Headquarter Location

599 Lexington Avenue 20th Floor

New York, New York, 10022,

United States

+1 646 562 1010

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Cowen News

New Research Coverage Highlights HomeStreet, Cousins Properties, Carbo Ceramics, Cowen Group, CTS, and NovoCure — Consolidated Revenues, Company Growth, and Expectations for 2018

Oct 30, 2018

| Source: Fundamental Markets NEW YORK, Oct. 30, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of HomeStreet, Inc. (NASDAQ: HMST ), Cousins Properties Incorporated (NYSE: CUZ ), Carbo Ceramics, Inc. (NYSE: CRR ), Cowen Group, Inc. (NASDAQ: COWN ), CTS Corporation (NYSE: CTS ), and NovoCure Limited (NASDAQ: NVCR ), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research. Complimentary Access: Research Reports (You may have to copy and paste the link into your browser and hit the [ENTER] key) The new research reports from Fundamental Markets, available for free download at the links above, examine HomeStreet, Inc. (NASDAQ: HMST ), Cousins Properties Incorporated (NYSE: CUZ ), Carbo Ceramics, Inc. (NYSE: CRR ), Cowen Group, Inc. (NASDAQ: COWN ), CTS Corporation (NYSE: CTS ), and NovoCure Limited (NASDAQ: NVCR ) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below. ----------------------------------------- Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed October 26th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts. ----------------------------------------- HomeStreet's Recent Financial Performance For the three months ended June 30th, 2018 vs June 30th, 2017, HomeStreet reported interest income of $67.19MM vs $56.74MM (up 18.41%) and analysts estimated basic earnings per share $0.26 vs $0.42 (down 38.10%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, HomeStreet reported interest income of $237.68MM vs $209.54MM (up 13.43%) and analysts estimated basic earnings per share $2.57 vs $2.36 (up 8.90%). Analysts expect earnings to be released on January 28th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.43. The estimated EPS forecast for the next fiscal year is $2.24 and is expected to report on January 28th, 2019. To read the full HomeStreet, Inc. (HMST) report, download it here: http://Fundamental-Markets.com/register/?so=HMST ----------------------------------------- Cousins Properties' Recent Financial Performance For the three months ended September 30th, 2018 vs September 30th, 2017, Cousins Properties reported revenue of $118.71MM vs $113.16MM (up 4.90%) and analysts estimated basic earnings per share $0.05 vs $0.03 (up 66.67%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Cousins Properties reported revenue of $466.19MM vs $259.21MM (up 79.85%) and analysts estimated basic earnings per share $0.52 vs $0.31 (up 67.74%). Analysts expect earnings to be released on February 6th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.15. The estimated EPS forecast for the next fiscal year is $0.64 and is expected to report on February 6th, 2019. To read the full Cousins Properties Incorporated (CUZ) report, download it here: http://Fundamental-Markets.com/register/?so=CUZ ----------------------------------------- Carbo Ceramics' Recent Financial Performance For the three months ended September 30th, 2018 vs September 30th, 2017, Carbo Ceramics reported revenue of $53.82MM vs $50.17MM (up 7.27%) and analysts estimated basic earnings per share -$0.62 vs -$6.69. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Carbo Ceramics reported revenue of $188.76MM vs $103.05MM (up 83.17%) and analysts estimated basic earnings per share -$9.49 vs -$3.29. Analysts expect earnings to be released on January 24th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.65. The estimated EPS forecast for the next fiscal year is -$0.23 and is expected to report on January 24th, 2019. To read the full Carbo Ceramics, Inc. (CRR) report, download it here: http://Fundamental-Markets.com/register/?so=CRR ----------------------------------------- Cowen Group's Recent Financial Performance For the three months ended June 30th, 2018 vs June 30th, 2017, Cowen Group reported revenue of $234.57MM vs $160.53MM (up 46.12%) and basic earnings per share $0.12 vs $0.20 (down 40.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Cowen Group reported revenue of $658.78MM vs $471.57MM (up 39.70%) and analysts estimated basic earnings per share -$2.29 vs -$0.97. Analysts expect earnings to be released on February 21st, 2019. The report will be for the fiscal period ending December 31st, 2018. To read the full Cowen Group, Inc. (COWN) report, download it here: http://Fundamental-Markets.com/register/?so=COWN ----------------------------------------- CTS's Recent Financial Performance For the three months ended September 30th, 2018 vs September 30th, 2017, CTS reported revenue of $118.86MM vs $106.24MM (up 11.87%) and analysts estimated basic earnings per share $0.31 vs $0.29 (up 6.90%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, CTS reported revenue of $422.99MM vs $396.68MM (up 6.63%) and analysts estimated basic earnings per share $0.44 vs $1.05 (down 58.10%). Analysts expect earnings to be released on February 5th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.39. The estimated EPS forecast for the next fiscal year is $1.60 and is expected to report on February 5th, 2019. To read the full CTS Corporation (CTS) report, download it here: http://Fundamental-Markets.com/register/?so=CTS ----------------------------------------- NovoCure's Recent Financial Performance For the three months ended September 30th, 2018 vs September 30th, 2017, NovoCure reported revenue of $64.76MM vs $50.11MM (up 29.23%) and analysts estimated basic earnings per share -$0.13 vs -$0.13. For the twelve months ended December 31st, 2017 vs December 31st, 2016, NovoCure reported revenue of $177.03MM vs $82.89MM (up 113.57%) and analysts estimated basic earnings per share -$0.70 vs -$1.54. Analysts expect earnings to be released on February 28th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.12. The estimated EPS forecast for the next fiscal year is $0.23 and is expected to report on February 28th, 2019. To read the full NovoCure Limited (NVCR) report, download it here: http://Fundamental-Markets.com/register/?so=NVCR ----------------------------------------- ABOUT FUNDAMENTAL MARKETS Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about. REGISTERED MEMBER STATUS Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com. LEGAL NOTICES Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website. Media Contact:

Cowen Investments

183 Investments

Cowen has made 183 investments. Their latest investment was in Polysign as part of their Series C on April 4, 2022.

CBI Logo

Cowen Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/13/2022

Series C

Polysign

$52.87M

No

3

3/30/2022

Series C

Neuron23

$100M

No

2

2/24/2022

Series D

Scipher Medicine

$110M

Yes

12

2/16/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

2/16/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/13/2022

3/30/2022

2/24/2022

2/16/2022

2/16/2022

Round

Series C

Series C

Series D

Series A

Series B

Company

Polysign

Neuron23

Scipher Medicine

Subscribe to see more

Subscribe to see more

Amount

$52.87M

$100M

$110M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

2

12

10

10

Cowen Portfolio Exits

79 Portfolio Exits

Cowen has 79 portfolio exits. Their latest portfolio exit was Personal Genome Diagnostics on December 23, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/23/2021

Acquired

$99M

12

7/30/2021

IPO

$99M

6

6/15/2021

Reverse Merger

$99M

8

4/9/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

3/26/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/23/2021

7/30/2021

6/15/2021

4/9/2021

3/26/2021

Exit

Acquired

IPO

Reverse Merger

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

12

6

8

10

10

Cowen Acquisitions

11 Acquisitions

Cowen acquired 11 companies. Their latest acquisition was Portico Capital Securities on November 23, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

11/23/2021

$99M

Acq - Fin

1

9/15/2020

Debt

$99M

$0.68M

Acquired

4

11/20/2018

$99M

Acquired

3

4/3/2017

Subscribe to see more

$99M

Subscribe to see more

10

3/22/2016

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/23/2021

9/15/2020

11/20/2018

4/3/2017

3/22/2016

Investment Stage

Debt

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$0.68M

Note

Acq - Fin

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Sources

1

4

3

10

10

Cowen Fund History

4 Fund Histories

Cowen has 4 funds, including Cowen Healthcare Investments III.

Closing Date

Fund

Fund Type

Status

Amount

Sources

5/19/2020

Cowen Healthcare Investments III

$493M

2

9/24/2019

CHI EF III

$99M

10

11/13/2017

CHI Employee Fund II

$99M

10

11/13/2017

Cowen Healthcare Investments II

$99M

10

Closing Date

5/19/2020

9/24/2019

11/13/2017

11/13/2017

Fund

Cowen Healthcare Investments III

CHI EF III

CHI Employee Fund II

Cowen Healthcare Investments II

Fund Type

Status

Amount

$493M

$99M

$99M

$99M

Sources

2

10

10

10

Cowen Partners & Customers

10 Partners and customers

Cowen has 10 strategic partners and customers. Cowen recently partnered with Standard Custody on June 6, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

6/1/2021

Partner

United States

5/5/2021

Vendor

United States

TORA OEMS Chosen for Fixed Income by Cowen Outsourced Trading - TORA

Chris Jenkins , Managing Director at TORA commented `` We are delighted to have been selected by Cowen .

1

2/4/2020

Partner

United Kingdom

Cowen to Integrate the Prime Brokerage Business of Global Prime Partners

04 , 2020 -- Cowen Inc. today announced that it has entered into an agreement to cooperate with Global to transition GPP 's International Prime Brokerage business to Cowen Inc. .

1

12/11/2019

Partner

United States

Subscribe to see more

Subscribe to see more

10

7/8/2019

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

6/1/2021

5/5/2021

2/4/2020

12/11/2019

7/8/2019

Type

Partner

Vendor

Partner

Partner

Partner

Business Partner

Country

United States

United States

United Kingdom

United States

United States

News Snippet

TORA OEMS Chosen for Fixed Income by Cowen Outsourced Trading - TORA

Chris Jenkins , Managing Director at TORA commented `` We are delighted to have been selected by Cowen .

Cowen to Integrate the Prime Brokerage Business of Global Prime Partners

04 , 2020 -- Cowen Inc. today announced that it has entered into an agreement to cooperate with Global to transition GPP 's International Prime Brokerage business to Cowen Inc. .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

1

10

10

Cowen Team

43 Team Members

Cowen has 43 team members, including current Chief Executive Officer, Peter A. Cohen.

Name

Work History

Title

Status

Anand Kannappan

Founder

Current

Peter A. Cohen

Chief Executive Officer

Current

Greg Malcolm

Chief Executive Officer, President

Current

William Marr

Chief Executive Officer, President

Current

Thomas W. Strauss

Chief Executive Officer, President

Current

Name

Anand Kannappan

Peter A. Cohen

Greg Malcolm

William Marr

Thomas W. Strauss

Work History

Title

Founder

Chief Executive Officer

Chief Executive Officer, President

Chief Executive Officer, President

Chief Executive Officer, President

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.